• Thumbnail for Covaxin
    Covaxin (development name, BBV152) is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council...
    42 KB (3,848 words) - 07:08, 24 September 2024
  • company were responsible for developing India's own COVID-19 vaccine, Covaxin, World's 1st clinically proven conjugated Typhoid Vaccine, TypbarTCV and...
    11 KB (822 words) - 10:06, 19 May 2024
  • Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi–GSK. Seven others are under assessment...
    322 KB (19,558 words) - 03:33, 16 September 2024
  • Thumbnail for COVID-19 vaccination in India
    license by Serum Institute of India under the trade name Covishield) and Covaxin (a vaccine developed locally by Bharat Biotech). They have since been joined...
    181 KB (11,351 words) - 23:42, 5 August 2024
  • Thumbnail for Covaxgate
    Covaxgate (redirect from Case Covaxin)
    The Case Covaxin, also known as Covaxgate, refers to an investigation made by the Brazilian Federal Public Ministry (MPF), held on June 16, 2021, which...
    15 KB (1,189 words) - 21:09, 28 August 2024
  • Thumbnail for Bharat Biotech
    2 clinical trials in India for a developmental COVID-19 vaccine named Covaxin, from the Drugs Controller General of India (DCGI), Government of India...
    19 KB (1,339 words) - 15:45, 22 September 2024
  • Thumbnail for Vaccine Maitri
    peacekeeping missions. India has two approved COVID-19 vaccines: Covishield and Covaxin. Both of them were exported and used in foreign grants by the Government...
    23 KB (1,325 words) - 22:34, 17 July 2024
  • Thumbnail for Anil Vij
    NDTV.com. Retrieved 20 November 2020. "Want to speed up vaccine trial: Covaxin volunteer Anil Vij". The Indian Express. 20 November 2020. Retrieved 20...
    9 KB (535 words) - 16:53, 25 October 2024
  • January 2021 with AstraZeneca vaccine (Covishield) and the indigenous Covaxin. Later, Sputnik V and the Moderna vaccine was approved for emergency use...
    337 KB (26,346 words) - 02:10, 4 November 2024
  • Thumbnail for COVID-19 pandemic
    hesitancy US Vaccine card Vaccine passports Current vaccines CoronaVac Covaxin Convidecia Janssen Medigen Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech...
    369 KB (32,739 words) - 05:44, 2 November 2024